These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22188361)

  • 21. Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.
    Kang S; Ju W; Kim JW; Park NH; Song YS; Kim SC; Park SY; Kang SB; Lee HP
    Exp Mol Med; 2006 Jun; 38(3):320-4. PubMed ID: 16819291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population.
    You WC; Hong JY; Zhang L; Pan KF; Pee D; Li JY; Ma JL; Rothman N; Caporaso N; Fraumeni JF; Xu GW; Gail MH
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):451-8. PubMed ID: 15734972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?
    Fariña Sarasqueta A; van Lijnschoten G; Lemmens VE; Rutten HJ; van den Brule AJ
    Mol Diagn Ther; 2011 Oct; 15(5):277-83. PubMed ID: 21958378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are polymorphisms in metabolism protective or a risk for reduced white blood cell counts in a Chinese population with low occupational benzene exposures?
    Ye LL; Zhang GH; Huang JW; Li Y; Zheng GQ; Zhang DT; Zhou LF; Tao XD; Zhang J; Ye YJ; Sun P; Frank A; Xia ZL
    Int J Occup Environ Health; 2015; 21(3):232-40. PubMed ID: 26179485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population.
    Li HY; Ge X; Huang GM; Li KY; Zhao JQ; Yu XM; Bi WS; Wang YL
    Asian Pac J Cancer Prev; 2012; 13(7):3465-9. PubMed ID: 22994779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients.
    Morari EC; Lima AB; Bufalo NE; Leite JL; Granja F; Ward LS
    J Cancer Res Clin Oncol; 2006 Aug; 132(8):521-8. PubMed ID: 16788846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms of ERCC1‑118, XRCC1‑399 and GSTP1‑105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin‑based adjuvant chemotherapy.
    Liu YP; Ling Y; Qi QF; Zhang YP; Zhang CS; Zhu CT; Wang MH; Pan YD
    Mol Med Rep; 2013 Jun; 7(6):1904-11. PubMed ID: 23604281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione S-transferase gene polymorphisms and susceptibility to acute myeloid leukemia: meta-analyses.
    He HR; You HS; Sun JY; Hu SS; Ma Y; Dong YL; Lu J
    Jpn J Clin Oncol; 2014 Nov; 44(11):1070-81. PubMed ID: 25145382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association between polymorphisms of ERCC1 and response in patients with advanced non-small cell lung cancer receiving cisplatin-based chemotherapy].
    Wang J; Zhang Q; Zhang H; Wang Q; Yang X; Gu Y; Zhang S
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):337-41. PubMed ID: 20677561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect of ERCC1 polymorphisms.
    Tzvetkov MV; Behrens G; O'Brien VP; Hohloch K; Brockmöller J; Benöhr P
    Pharmacogenomics; 2011 Oct; 12(10):1417-27. PubMed ID: 21902499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.
    Glesse N; Rohr P; Monticielo OA; Rech TF; Brenol JC; Xavier RM; Kvitko K; Chies JA
    Mol Biol Rep; 2014 Sep; 41(9):6167-79. PubMed ID: 24981927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
    Booton R; Ward T; Heighway J; Ashcroft L; Morris J; Thatcher N
    J Thorac Oncol; 2006 Sep; 1(7):679-83. PubMed ID: 17409936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
    Bao Y; Yang B; Zhao J; Shen S; Gao J
    Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population.
    Sharma N; Singh A; Singh N; Behera D; Sharma S
    Cancer Epidemiol; 2015 Dec; 39(6):947-55. PubMed ID: 26529288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome.
    Medeiros R; Pereira D; Afonso N; Palmeira C; Faleiro C; Afonso-Lopes C; Freitas-Silva M; Vasconcelos A; Costa S; Osório T; Lopes C
    Int J Clin Oncol; 2003 Jun; 8(3):156-61. PubMed ID: 12851839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of ERCC1 and their effects on the efficacy of cisplatin-based chemotherapy in advanced esophageal carcinoma.
    Wang Y; Chen J; Li X; He Y; Hu B; Ji C; Xu J
    Oncol Rep; 2011 Apr; 25(4):1047-52. PubMed ID: 21286668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 May; 121(1):195-202. PubMed ID: 19760040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of XRCC1, GSTP1, and GSTM1 Polymorphisms on the Survival of Ovarian Carcinoma Patients Treated with Chemotherapy.
    Zhai XH; Huang J; Wu FX; Zhu DY; Wang AC
    Oncol Res Treat; 2016; 39(7-8):440-6. PubMed ID: 27487108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
    Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.